Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview
461studies shown
Showing 349-360 of 461
Drug study icon
CompletedNCT00868452

Lurasidone - A 6-week Study of people with Bipolar I Depression (Add-on)

This study is completed. It focuses on bipolarity and currently lists study information in Czech Republic, France, Germany, India, Poland, Romania, Russian Federation, South Africa, Ukraine, and the United States.

In France
Bipolarity, DepressionDrugA study involving a medication or substance.From 18 Years to 75 Years
Countries
United States, France, Czech Republic, ...
Sponsor
Sumitomo Pharma America, Inc.
Condition
Bipolarity, Depression
Drug study icon
CompletedNCT00868699

Lurasidone - A 6-week Study of people with Bipolar I Depression (Monotherapy)

This study is completed. It focuses on bipolarity and currently lists study information in Czech Republic, France, India, Romania, Russian Federation, South Africa, Ukraine, and the United States.

In France
Bipolarity, DepressionDrugFrom 18 Years to 75 Years
Countries
United States, France, Czech Republic, ...
Sponsor
Sumitomo Pharma America, Inc.
Condition
Bipolarity, Depression
Drug study icon
CompletedNCT01485640

Lurasidone Extended Use Study

This study is completed. It focuses on schizophrenia and currently lists study information in Canada, Colombia, Czech Republic, France, India, Lithuania, Romania, Russian Federation, Serbia, Slovakia, South Africa, and Ukraine.

In France
Schizophrenia, BipolarityDrug
Countries
France, Canada, Colombia, ...
Sponsor
Sumitomo Pharma America, Inc.
Condition
Schizophrenia, Bipolarity
Drug study icon
CompletedNCT02046369

Lurasidone Pediatric Bipolar Study

This study is completed. It focuses on bipolarity and currently lists study information in Bulgaria, Colombia, France, Hungary, Mexico, the Philippines, Poland, the United States, South Korea, and Ukraine.

In France
Bipolarity, DepressionDrugFrom 10 Years to 17 Years
Countries
United States, France, Bulgaria, ...
Sponsor
Sumitomo Pharma America, Inc.
Condition
Bipolarity, Depression
Biological study icon
CompletedNCT00998231

Major Depression and Messenger RNAs

This study is completed. It focuses on depression and currently lists study information in France.

In France
DepressionBiologicalOver 18 Years
Countries
France
Sponsor
Assistance Publique Hopitaux De Marseille
Condition
Depression
Other study type icon
CompletedNCT07380074

Mental Health Outcomes and Variations in Exercise in Residents

This study is completed. It focuses on anxiety and currently lists study information in France.

In France
Anxiety, DepressionDiagnostic TestA study that looks at how to detect, measure, or better understand a condition.Over 18 Years
Countries
France
Sponsor
University Hospital, Caen
Condition
Anxiety, Depression
Behavioral study icon
TerminatedNCT03318640

Mindfulness and Cognition in Schizophrenia

This study has public registry information. It focuses on schizophrenia and currently lists study information in France.

In France
SchizophreniaBehavioralFrom 18 Years to 55 Years
Countries
France
Sponsor
Centre Hospitalier Universitaire de Saint Etienne
Condition
Schizophrenia
Behavioral study icon
CompletedNCT04043052

Mobile Technologies and Post-stroke Depression

This study is completed. It focuses on depression and currently lists study information in France.

In France
DepressionBehavioralOver 18 Years
Countries
France
Sponsor
University Hospital, Bordeaux
Condition
Depression
France | Clinical Trials | HopeStage Research